ZAS Pharma Ltd

ZAS Pharma Ltd. is a pharmaceutical export company focused on delivering tailored specialty healthcare solutions across international markets. With more than 20 years of experience and activity in over 80 countries, the company works through a multi-regional manufacturing and partnership network. Its portfolio includes rare disease therapies, oncology products, biosimilars, antiviral medicines, blood derivatives, GLP-1 generics, and other complex or niche treatments, including cytotoxic, oral oncology, and recombinant products. ZAS Pharma reports more than 400 marketing authorizations worldwide and over 200 specialty and niche products in its pipeline.

The company offers integrated services spanning licensing, manufacturing, marketing, logistics, regulatory affairs, and global market access. Support includes CTD dossier preparation and submission, approval processes, post-approval monitoring, and named-patient and special-access programs. Its products and services are supported by clinical and bioequivalence studies, pharmacist-led quality control, and pharmacovigilance that monitors safety and manages adverse-event reports. ZAS Pharma states that it adheres to international requirements, including EMA, EU GMP, and PICS standards, and aims to provide ethical, high-quality medicines at fair prices.